NCT01648452View on ClinicalTrials.gov

CNTF Implants for CNGB3 Achromatopsia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

October 31, 2015

Conditions
Eye DiseaseAchromatopsia
Interventions
BIOLOGICAL

NT-501 CNTF-releasing implant

20 ng/day released into the eye

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT01648452 - CNTF Implants for CNGB3 Achromatopsia | Biotech Hunter | Biotech Hunter